Publications
49
Citations
1,128
Est. group size
~4
Recurring co-author estimate
Active years
22
Publishing since 2005
Typically publishes in teams of ~20 · 7% small-team papers (≤3 authors) · across 10 venues
- Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Cureus · 2022
- Clinical effects of morning and afternoon radiotherapy on high-grade gliomas
Chronobiology International · 2021
- Risk of in-hospital death associated with Covid-19 lung consolidations on chest computed tomography – A novel translational approach using a radiation oncology contour software
European Journal of Radiology Open · 2021
- Clinical Predictors of Definitive Treatment Interruptions of Long-course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Research Square · 2021
- AUTHOR REPLY
Urology · 2021
- Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer
International Journal of Gynecological Cancer · 2020
- Outcomes and Toxicity following Salvage Radiotherapy for Vaginal Relapse of Endometrial Cancer
International Journal of Radiation Oncology*Biology*Physics · 2020
- Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
European Urology · 2019
- Clinical Outcomes among Patients with Radiorecurrent Gleason Grade Group 5 Prostate Cancer: Impact of Initial Treatment Strategy
International Journal of Radiation Oncology*Biology*Physics · 2019
- Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
JAMA · 2018
- Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
International Journal of Radiation Oncology*Biology*Physics · 2018
- Clinical outcomes following biochemical recurrence among patients with Gleason score 9-10 prostate adenocarcinoma.
Journal of Clinical Oncology · 2018
- Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-institutional Consortium Study
International Journal of Radiation Oncology*Biology*Physics · 2017
- Whole Pelvis Radiation Therapy Does Not Significantly Improve Prostate-Cancer Specific Survival in Patients With Gleason Score 9-10 Prostate Adenocarcinoma: An Analysis of 942 Patients Treated in the Modern Era
International Journal of Radiation Oncology*Biology*Physics · 2017
- Extremely Dose Escalated Radiation Therapy Improves Cancer-Specific Survival Compared With Radical Prostatectomy or Conventionally Dose-Escalated Radiation Therapy in Gleason Score 9-10 Prostate Adenocarcinoma: A Multi-institutional Analysis of 1403 Patie
International Journal of Radiation Oncology*Biology*Physics · 2017
- International Journal of Radiation Oncology*Biology*Physics×16
- JAMA Oncology×2
- JAMA Network Open×2
- European Urology×2
- Urology×2
- Robert T. Dess
Medicine · University of Michigan
- Will Jackson
Medicine · University of Michigan
- Vrinda Narayana
Medicine · University of Michigan
- Patrick W. McLaughlin
Medicine · University of Michigan
- Sonia Gaur
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile